Invention Grant
- Patent Title: Use of benzimidazole-proline derivatives
-
Application No.: US15101871Application Date: 2014-12-03
-
Publication No.: US09914721B2Publication Date: 2018-03-13
- Inventor: Christoph Boss , Catherine Roch , Christine Brotschi , Markus Gude , Bibia Heidmann , Francois Jenck , Thierry Sifferlen , Michel Steiner , Jodi T. Williams
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/IB2013/060630 20131204
- International Application: PCT/IB2014/066548 WO 20141203
- International Announcement: WO2015/083094 WO 20150611
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; C07D403/14 ; A61K31/4178 ; A61K31/4192 ; A61K31/506
Abstract:
The present invention relates to compounds of the formula (I) wherein Ar1 and Ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20170001985A1 USE OF BENZIMIDAZOLE-PROLINE DERIVATIVES Public/Granted day:2017-01-05
Information query
IPC分类:
